Fig. 7
Silencing METTL3 can reduce the m6A modification of MALAT1, down-regulate the level of MALAT1, decrease the expression of HMGA2 by sponging miR-26b, and finally inhibit EMT in BC
Fig. 7 | Cancer Cell International
Silencing METTL3 can reduce the m6A modification of MALAT1, down-regulate the level of MALAT1, decrease the expression of HMGA2 by sponging miR-26b, and finally inhibit EMT in BC